APO Research
Talk to an analyst

APO RESEARCH · REPORT

GLP-1 Weight Loss Injection

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global GLP-1 Weight Loss Injection Market Analysis and Forecast 2026-2032

26 December 2025190 pages

Choose your research edition.

Industry ResearchGLP-1 Weight Loss Injection Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal GLP-1 Weight Loss Injection Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal GLP-1 Weight Loss Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal GLP-1 Weight Loss Injection Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal GLP-1 Weight Loss Injection Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global GLP-1 Weight Loss Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for GLP-1 Weight Loss Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for GLP-1 Weight Loss Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for GLP-1 Weight Loss Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for GLP-1 Weight Loss Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of GLP-1 Weight Loss Injection include Novo Nordisk, Imeik, Borui Pharmaceuticals, Gan & Lee Pharmaceuticals, Hansoh Pharmaceuticals, Hengrui Medicine, Huadong Medicine, Eli Lilly and Shanghai Benemae Biopharmaceuticals Co., Ltd., etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for GLP-1 Weight Loss Injection, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of GLP-1 Weight Loss Injection, also provides the sales of main regions and countries. Of the upcoming market potential for GLP-1 Weight Loss Injection, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the GLP-1 Weight Loss Injection sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global GLP-1 Weight Loss Injection market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for GLP-1 Weight Loss Injection sales, projected growth trends, production technology, application and end-user industry.

GLP-1 Weight Loss Injection Segment by Company

Novo Nordisk

Imeik

Borui Pharmaceuticals

Gan & Lee Pharmaceuticals

Hansoh Pharmaceuticals

Hengrui Medicine

Huadong Medicine

Eli Lilly

Shanghai Benemae Biopharmaceuticals Co., Ltd.

CSPC Pharmaceutical Group

Sihuan Pharmaceuticals

Wanbang Biopharma

Innovent Biologics

GLP-1 Weight Loss Injection Segment by Type

Tirzepatide

Semaglutide

Liraglutide

Benaglutide

Others

GLP-1 Weight Loss Injection Segment by Application

Hospital

Clinic

Others

GLP-1 Weight Loss Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global GLP-1 Weight Loss Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of GLP-1 Weight Loss Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of GLP-1 Weight Loss Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of GLP-1 Weight Loss Injection in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of GLP-1 Weight Loss Injection manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, GLP-1 Weight Loss Injection sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global GLP-1 Weight Loss Injection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Tirzepatide Major Manufacturers Table 3. Semaglutide Major Manufacturers Table 4. Liraglutide Major Manufacturers Table 5. Benaglutide Major Manufacturers Table 6. Others Major Manufacturers Table 7. Global GLP-1 Weight Loss Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Hospital Major Manufacturers Table 9. Clinic Major Manufacturers Table 10. Others Major Manufacturers Table 11. GLP-1 Weight Loss Injection Industry Trends Table 12. GLP-1 Weight Loss Injection Industry Drivers Table 13. GLP-1 Weight Loss Injection Industry Opportunities and Challenges Table 14. GLP-1 Weight Loss Injection Industry Restraints Table 15. Global GLP-1 Weight Loss Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 16. Global GLP-1 Weight Loss Injection Revenue by Region (2021-2026) & (US$ Million) Table 17. Global GLP-1 Weight Loss Injection Revenue by Region (2027-2032) & (US$ Million) Table 18. Global GLP-1 Weight Loss Injection Revenue Market Share by Region (2021-2026) Table 19. Global GLP-1 Weight Loss Injection Revenue Market Share by Region (2027-2032) Table 20. Global GLP-1 Weight Loss Injection Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 21. Global GLP-1 Weight Loss Injection Sales by Region (2021-2026) & (K Units) Table 22. Global GLP-1 Weight Loss Injection Sales by Region (2027-2032) & (K Units) Table 23. Global GLP-1 Weight Loss Injection Sales Market Share by Region (2021-2026) Table 24. Global GLP-1 Weight Loss Injection Sales Market Share by Region (2027-2032) Table 25. Global GLP-1 Weight Loss Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 26. Global GLP-1 Weight Loss Injection Revenue Market Share by Manufacturers (2021-2026) Table 27. Global GLP-1 Weight Loss Injection Sales by Manufacturers (US$ Million) & (2021-2026) Table 28. Global GLP-1 Weight Loss Injection Sales Market Share by Manufacturers (2021-2026) Table 29. Global GLP-1 Weight Loss Injection Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 30. Global GLP-1 Weight Loss Injection Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 31. Global GLP-1 Weight Loss Injection Key Manufacturers Manufacturing Sites & Headquarters Table 32. Global GLP-1 Weight Loss Injection Manufacturers, Product Type & Application Table 33. Global GLP-1 Weight Loss Injection Manufacturers' Establishment Date Table 34. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 35. Global GLP-1 Weight Loss Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 36. Global GLP-1 Weight Loss Injection Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global GLP-1 Weight Loss Injection Revenue by Type (2021-2026) & (US$ Million) Table 38. Global GLP-1 Weight Loss Injection Revenue by Type (2027-2032) & (US$ Million) Table 39. Global GLP-1 Weight Loss Injection Revenue Market Share by Type (2021-2026) Table 40. Global GLP-1 Weight Loss Injection Revenue Market Share by Type (2027-2032) Table 41. Global GLP-1 Weight Loss Injection Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 42. Global GLP-1 Weight Loss Injection Sales by Type (2021-2026) & (K Units) Table 43. Global GLP-1 Weight Loss Injection Sales by Type (2027-2032) & (K Units) Table 44. Global GLP-1 Weight Loss Injection Sales Market Share by Type (2021-2026) Table 45. Global GLP-1 Weight Loss Injection Sales Market Share by Type (2027-2032) Table 46. Global GLP-1 Weight Loss Injection Price by Type (2021-2026) & (US$/Unit) Table 47. Global GLP-1 Weight Loss Injection Price by Type (2027-2032) & (US$/Unit) Table 48. Global GLP-1 Weight Loss Injection Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global GLP-1 Weight Loss Injection Revenue by Application (2021-2026) & (US$ Million) Table 50. Global GLP-1 Weight Loss Injection Revenue by Application (2027-2032) & (US$ Million) Table 51. Global GLP-1 Weight Loss Injection Revenue Market Share by Application (2021-2026) Table 52. Global GLP-1 Weight Loss Injection Revenue Market Share by Application (2027-2032) Table 53. Global GLP-1 Weight Loss Injection Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 54. Global GLP-1 Weight Loss Injection Sales by Application (2021-2026) & (K Units) Table 55. Global GLP-1 Weight Loss Injection Sales by Application (2027-2032) & (K Units) Table 56. Global GLP-1 Weight Loss Injection Sales Market Share by Application (2021-2026) Table 57. Global GLP-1 Weight Loss Injection Sales Market Share by Application (2027-2032) Table 58. Global GLP-1 Weight Loss Injection Price by Application (2021-2026) & (US$/Unit) Table 59. Global GLP-1 Weight Loss Injection Price by Application (2027-2032) & (US$/Unit) Table 60. Novo Nordisk Company Information Table 61. Novo Nordisk Business Overview Table 62. Novo Nordisk GLP-1 Weight Loss Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 63. Novo Nordisk GLP-1 Weight Loss Injection Product Portfolio Table 64. Novo Nordisk Recent Development Table 65. Imeik Company Information Table 66. Imeik Business Overview Table 67. Imeik GLP-1 Weight Loss Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Imeik GLP-1 Weight Loss Injection Product Portfolio Table 69. Imeik Recent Development Table 70. Borui Pharmaceuticals Company Information Table 71. Borui Pharmaceuticals Business Overview Table 72. Borui Pharmaceuticals GLP-1 Weight Loss Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Borui Pharmaceuticals GLP-1 Weight Loss Injection Product Portfolio Table 74. Borui Pharmaceuticals Recent Development Table 75. Gan & Lee Pharmaceuticals Company Information Table 76. Gan & Lee Pharmaceuticals Business Overview Table 77. Gan & Lee Pharmaceuticals GLP-1 Weight Loss Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Gan & Lee Pharmaceuticals GLP-1 Weight Loss Injection Product Portfolio Table 79. Gan & Lee Pharmaceuticals Recent Development Table 80. Hansoh Pharmaceuticals Company Information Table 81. Hansoh Pharmaceuticals Business Overview Table 82. Hansoh Pharmaceuticals GLP-1 Weight Loss Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Hansoh Pharmaceuticals GLP-1 Weight Loss Injection Product Portfolio Table 84. Hansoh Pharmaceuticals Recent Development Table 85. Hengrui Medicine Company Information Table 86. Hengrui Medicine Business Overview Table 87. Hengrui Medicine GLP-1 Weight Loss Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Hengrui Medicine GLP-1 Weight Loss Injection Product Portfolio Table 89. Hengrui Medicine Recent Development Table 90. Huadong Medicine Company Information Table 91. Huadong Medicine Business Overview Table 92. Huadong Medicine GLP-1 Weight Loss Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Huadong Medicine GLP-1 Weight Loss Injection Product Portfolio Table 94. Huadong Medicine Recent Development Table 95. Eli Lilly Company Information Table 96. Eli Lilly Business Overview Table 97. Eli Lilly GLP-1 Weight Loss Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Eli Lilly GLP-1 Weight Loss Injection Product Portfolio Table 99. Eli Lilly Recent Development Table 100. Shanghai Benemae Biopharmaceuticals Co., Ltd. Company Information Table 101. Shanghai Benemae Biopharmaceuticals Co., Ltd. Business Overview Table 102. Shanghai Benemae Biopharmaceuticals Co., Ltd. GLP-1 Weight Loss Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Shanghai Benemae Biopharmaceuticals Co., Ltd. GLP-1 Weight Loss Injection Product Portfolio Table 104. Shanghai Benemae Biopharmaceuticals Co., Ltd. Recent Development Table 105. CSPC Pharmaceutical Group Company Information Table 106. CSPC Pharmaceutical Group Business Overview Table 107. CSPC Pharmaceutical Group GLP-1 Weight Loss Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. CSPC Pharmaceutical Group GLP-1 Weight Loss Injection Product Portfolio Table 109. CSPC Pharmaceutical Group Recent Development Table 110. Sihuan Pharmaceuticals Company Information Table 111. Sihuan Pharmaceuticals Business Overview Table 112. Sihuan Pharmaceuticals GLP-1 Weight Loss Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. Sihuan Pharmaceuticals GLP-1 Weight Loss Injection Product Portfolio Table 114. Sihuan Pharmaceuticals Recent Development Table 115. Wanbang Biopharma Company Information Table 116. Wanbang Biopharma Business Overview Table 117. Wanbang Biopharma GLP-1 Weight Loss Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. Wanbang Biopharma GLP-1 Weight Loss Injection Product Portfolio Table 119. Wanbang Biopharma Recent Development Table 120. Innovent Biologics Company Information Table 121. Innovent Biologics Business Overview Table 122. Innovent Biologics GLP-1 Weight Loss Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 123. Innovent Biologics GLP-1 Weight Loss Injection Product Portfolio Table 124. Innovent Biologics Recent Development Table 125. North America GLP-1 Weight Loss Injection Revenue by Type (2021-2026) & (US$ Million) Table 126. North America GLP-1 Weight Loss Injection Revenue by Type (2027-2032) & (US$ Million) Table 127. North America GLP-1 Weight Loss Injection Sales by Type (2021-2026) & (K Units) Table 128. North America GLP-1 Weight Loss Injection Sales by Type (2027-2032) & (K Units) Table 129. North America GLP-1 Weight Loss Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 130. North America GLP-1 Weight Loss Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 131. North America GLP-1 Weight Loss Injection Revenue by Application (2021-2026) & (US$ Million) Table 132. North America GLP-1 Weight Loss Injection Revenue by Application (2027-2032) & (US$ Million) Table 133. North America GLP-1 Weight Loss Injection Sales by Application (2021-2026) & (K Units) Table 134. North America GLP-1 Weight Loss Injection Sales by Application (2027-2032) & (K Units) Table 135. North America GLP-1 Weight Loss Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 136. North America GLP-1 Weight Loss Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 137. North America GLP-1 Weight Loss Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 138. North America GLP-1 Weight Loss Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 139. North America GLP-1 Weight Loss Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 140. North America GLP-1 Weight Loss Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 141. North America GLP-1 Weight Loss Injection Sales by Country (2021-2026) & (K Units) Table 142. North America GLP-1 Weight Loss Injection Sales by Country (2027-2032) & (K Units) Table 143. North America GLP-1 Weight Loss Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 144. North America GLP-1 Weight Loss Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 145. United States GLP-1 Weight Loss Injection Revenue (2021-2032) & (US$ Million) Table 146. Canada GLP-1 Weight Loss Injection Revenue (2021-2032) & (US$ Million) Table 147. Mexico GLP-1 Weight Loss Injection Revenue (2021-2032) & (US$ Million) Table 148. Europe GLP-1 Weight Loss Injection Revenue by Type (2021-2026) & (US$ Million) Table 149. Europe GLP-1 Weight Loss Injection Revenue by Type (2027-2032) & (US$ Million) Table 150. Europe GLP-1 Weight Loss Injection Sales by Type (2021-2026) & (K Units) Table 151. Europe GLP-1 Weight Loss Injection Sales by Type (2027-2032) & (K Units) Table 152. Europe GLP-1 Weight Loss Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 153. Europe GLP-1 Weight Loss Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 154. Europe GLP-1 Weight Loss Injection Revenue by Application (2021-2026) & (US$ Million) Table 155. Europe GLP-1 Weight Loss Injection Revenue by Application (2027-2032) & (US$ Million) Table 156. Europe GLP-1 Weight Loss Injection Sales by Application (2021-2026) & (K Units) Table 157. Europe GLP-1 Weight Loss Injection Sales by Application (2027-2032) & (K Units) Table 158. Europe GLP-1 Weight Loss Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 159. Europe GLP-1 Weight Loss Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 160. Europe GLP-1 Weight Loss Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 161. Europe GLP-1 Weight Loss Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 162. Europe GLP-1 Weight Loss Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 163. Europe GLP-1 Weight Loss Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 164. Europe GLP-1 Weight Loss Injection Sales by Country (2021-2026) & (K Units) Table 165. Europe GLP-1 Weight Loss Injection Sales by Country (2027-2032) & (K Units) Table 166. Europe GLP-1 Weight Loss Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 167. Europe GLP-1 Weight Loss Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 168. Germany GLP-1 Weight Loss Injection Revenue (2021-2032) & (US$ Million) Table 169. France GLP-1 Weight Loss Injection Revenue (2021-2032) & (US$ Million) Table 170. U.K. GLP-1 Weight Loss Injection Revenue (2021-2032) & (US$ Million) Table 171. Italy GLP-1 Weight Loss Injection Revenue (2021-2032) & (US$ Million) Table 172. Russia GLP-1 Weight Loss Injection Revenue (2021-2032) & (US$ Million) Table 173. Spain GLP-1 Weight Loss Injection Revenue (2021-2032) & (US$ Million) Table 174. Netherlands GLP-1 Weight Loss Injection Revenue (2021-2032) & (US$ Million) Table 175. Switzerland GLP-1 Weight Loss Injection Revenue (2021-2032) & (US$ Million) Table 176. Sweden GLP-1 Weight Loss Injection Revenue (2021-2032) & (US$ Million) Table 177. Poland GLP-1 Weight Loss Injection Revenue (2021-2032) & (US$ Million) Table 178. China GLP-1 Weight Loss Injection Revenue by Type (2021-2026) & (US$ Million) Table 179. China GLP-1 Weight Loss Injection Revenue by Type (2027-2032) & (US$ Million) Table 180. China GLP-1 Weight Loss Injection Sales by Type (2021-2026) & (K Units) Table 181. China GLP-1 Weight Loss Injection Sales by Type (2027-2032) & (K Units) Table 182. China GLP-1 Weight Loss Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 183. China GLP-1 Weight Loss Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 184. China GLP-1 Weight Loss Injection Revenue by Application (2021-2026) & (US$ Million) Table 185. China GLP-1 Weight Loss Injection Revenue by Application (2027-2032) & (US$ Million) Table 186. China GLP-1 Weight Loss Injection Sales by Application (2021-2026) & (K Units) Table 187. China GLP-1 Weight Loss Injection Sales by Application (2027-2032) & (K Units) Table 188. China GLP-1 Weight Loss Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 189. China GLP-1 Weight Loss Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 190. Asia GLP-1 Weight Loss Injection Revenue by Type (2021-2026) & (US$ Million) Table 191. Asia GLP-1 Weight Loss Injection Revenue by Type (2027-2032) & (US$ Million) Table 192. Asia GLP-1 Weight Loss Injection Sales by Type (2021-2026) & (K Units) Table 193. Asia GLP-1 Weight Loss Injection Sales by Type (2027-2032) & (K Units) Table 194. Asia GLP-1 Weight Loss Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 195. Asia GLP-1 Weight Loss Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 196. Asia GLP-1 Weight Loss Injection Revenue by Application (2021-2026) & (US$ Million) Table 197. Asia GLP-1 Weight Loss Injection Revenue by Application (2027-2032) & (US$ Million) Table 198. Asia GLP-1 Weight Loss Injection Sales by Application (2021-2026) & (K Units) Table 199. Asia GLP-1 Weight Loss Injection Sales by Application (2027-2032) & (K Units) Table 200. Asia GLP-1 Weight Loss Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 201. Asia GLP-1 Weight Loss Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 202. Asia GLP-1 Weight Loss Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 203. Asia GLP-1 Weight Loss Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 204. Asia GLP-1 Weight Loss Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 205. Asia GLP-1 Weight Loss Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 206. Asia GLP-1 Weight Loss Injection Sales by Country (2021-2026) & (K Units) Table 207. Asia GLP-1 Weight Loss Injection Sales by Country (2027-2032) & (K Units) Table 208. Asia GLP-1 Weight Loss Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 209. Asia GLP-1 Weight Loss Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 210. Japan GLP-1 Weight Loss Injection Revenue (2021-2032) & (US$ Million) Table 211. South Korea GLP-1 Weight Loss Injection Revenue (2021-2032) & (US$ Million) Table 212. India GLP-1 Weight Loss Injection Revenue (2021-2032) & (US$ Million) Table 213. Australia GLP-1 Weight Loss Injection Revenue (2021-2032) & (US$ Million) Table 214. Taiwan GLP-1 Weight Loss Injection Revenue (2021-2032) & (US$ Million) Table 215. Southeast Asia GLP-1 Weight Loss Injection Revenue (2021-2032) & (US$ Million) Table 216. SAMEA GLP-1 Weight Loss Injection Revenue by Type (2021-2026) & (US$ Million) Table 217. SAMEA GLP-1 Weight Loss Injection Revenue by Type (2027-2032) & (US$ Million) Table 218. SAMEA GLP-1 Weight Loss Injection Sales by Type (2021-2026) & (K Units) Table 219. SAMEA GLP-1 Weight Loss Injection Sales by Type (2027-2032) & (K Units) Table 220. SAMEA GLP-1 Weight Loss Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 221. SAMEA GLP-1 Weight Loss Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 222. SAMEA GLP-1 Weight Loss Injection Revenue by Application (2021-2026) & (US$ Million) Table 223. SAMEA GLP-1 Weight Loss Injection Revenue by Application (2027-2032) & (US$ Million) Table 224. SAMEA GLP-1 Weight Loss Injection Sales by Application (2021-2026) & (K Units) Table 225. SAMEA GLP-1 Weight Loss Injection Sales by Application (2027-2032) & (K Units) Table 226. SAMEA GLP-1 Weight Loss Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 227. SAMEA GLP-1 Weight Loss Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 228. SAMEA GLP-1 Weight Loss Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 229. SAMEA GLP-1 Weight Loss Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 230. SAMEA GLP-1 Weight Loss Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 231. SAMEA GLP-1 Weight Loss Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 232. SAMEA GLP-1 Weight Loss Injection Sales by Country (2021-2026) & (K Units) Table 233. SAMEA GLP-1 Weight Loss Injection Sales by Country (2027-2032) & (K Units) Table 234. SAMEA GLP-1 Weight Loss Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 235. SAMEA GLP-1 Weight Loss Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 236. Brazil GLP-1 Weight Loss Injection Revenue (2021-2032) & (US$ Million) Table 237. Argentina GLP-1 Weight Loss Injection Revenue (2021-2032) & (US$ Million) Table 238. Chile GLP-1 Weight Loss Injection Revenue (2021-2032) & (US$ Million) Table 239. Colombia GLP-1 Weight Loss Injection Revenue (2021-2032) & (US$ Million) Table 240. Peru GLP-1 Weight Loss Injection Revenue (2021-2032) & (US$ Million) Table 241. Saudi Arabia GLP-1 Weight Loss Injection Revenue (2021-2032) & (US$ Million) Table 242. Israel GLP-1 Weight Loss Injection Revenue (2021-2032) & (US$ Million) Table 243. UAE GLP-1 Weight Loss Injection Revenue (2021-2032) & (US$ Million) Table 244. Turkey GLP-1 Weight Loss Injection Revenue (2021-2032) & (US$ Million) Table 245. Iran GLP-1 Weight Loss Injection Revenue (2021-2032) & (US$ Million) Table 246. Egypt GLP-1 Weight Loss Injection Revenue (2021-2032) & (US$ Million) Table 247. Key Raw Materials Table 248. Raw Materials Key Suppliers Table 249. GLP-1 Weight Loss Injection Distributors List Table 250. GLP-1 Weight Loss Injection Customers List Table 251. Research Programs/Design for This Report Table 252. Authors List of This Report Table 253. Secondary Sources Table 254. Primary Sources List of Figures Figure 1. GLP-1 Weight Loss Injection Image Figure 2. Global GLP-1 Weight Loss Injection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global GLP-1 Weight Loss Injection Market Size Share 2021 VS 2025 VS 2032 Figure 4. Tirzepatide Image Figure 5. Semaglutide Image Figure 6. Liraglutide Image Figure 7. Benaglutide Image Figure 8. Others Image Figure 9. Global GLP-1 Weight Loss Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global GLP-1 Weight Loss Injection Market Size Share 2021 VS 2025 VS 2032 Figure 11. Hospital Image Figure 12. Clinic Image Figure 13. Others Image Figure 14. Global GLP-1 Weight Loss Injection Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global GLP-1 Weight Loss Injection Revenue (2021-2032) & (US$ Million) Figure 16. Global GLP-1 Weight Loss Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 17. Global GLP-1 Weight Loss Injection Revenue Market Share by Region: 2025 Versus 2032 Figure 18. Global GLP-1 Weight Loss Injection Revenue Market Share by Region (2021-2032) Figure 19. Global GLP-1 Weight Loss Injection Sales (2021-2032) & (K Units) Figure 20. Global GLP-1 Weight Loss Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 21. Global GLP-1 Weight Loss Injection Sales Market Share by Region (2021-2032) Figure 22. US & Canada & Mexico GLP-1 Weight Loss Injection Sales YoY (2021-2032) & (K Units) Figure 23. Europe GLP-1 Weight Loss Injection Sales YoY (2021-2032) & (K Units) Figure 24. China GLP-1 Weight Loss Injection Sales YoY (2021-2032) & (K Units) Figure 25. Asia (Excluding China) GLP-1 Weight Loss Injection Sales YoY (2021-2032) & (K Units) Figure 26. South America, Middle East and Africa GLP-1 Weight Loss Injection Sales YoY (2021-2032) & (K Units) Figure 27. Global GLP-1 Weight Loss Injection Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 28. Global GLP-1 Weight Loss Injection Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 29. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 30. Global GLP-1 Weight Loss Injection Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 31. Global GLP-1 Weight Loss Injection Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global GLP-1 Weight Loss Injection Revenue Market Share by Type (2021-2032) Figure 33. Global GLP-1 Weight Loss Injection Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 34. Global GLP-1 Weight Loss Injection Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global GLP-1 Weight Loss Injection Sales Market Share by Type (2021-2032) Figure 36. Global GLP-1 Weight Loss Injection Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 37. Global GLP-1 Weight Loss Injection Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global GLP-1 Weight Loss Injection Revenue Market Share by Application (2021-2032) Figure 39. Global GLP-1 Weight Loss Injection Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 40. Global GLP-1 Weight Loss Injection Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global GLP-1 Weight Loss Injection Sales Market Share by Application (2021-2032) Figure 42. North America GLP-1 Weight Loss Injection Revenue Share by Type (2021-2032) Figure 43. North America GLP-1 Weight Loss Injection Sales Share by Type (2021-2032) Figure 44. North America GLP-1 Weight Loss Injection Revenue Share by Application (2021-2032) Figure 45. North America GLP-1 Weight Loss Injection Sales Share by Application (2021-2032) Figure 46. North America GLP-1 Weight Loss Injection Revenue Share by Country (2021-2032) Figure 47. North America GLP-1 Weight Loss Injection Sales Share by Country (2021-2032) Figure 48. Europe GLP-1 Weight Loss Injection Revenue Share by Type (2021-2032) Figure 49. Europe GLP-1 Weight Loss Injection Sales Share by Type (2021-2032) Figure 50. Europe GLP-1 Weight Loss Injection Revenue Share by Application (2021-2032) Figure 51. Europe GLP-1 Weight Loss Injection Sales Share by Application (2021-2032) Figure 52. Europe GLP-1 Weight Loss Injection Revenue Share by Country (2021-2032) Figure 53. Europe GLP-1 Weight Loss Injection Sales Share by Country (2021-2032) Figure 54. China GLP-1 Weight Loss Injection Revenue Share by Type (2021-2032) Figure 55. China GLP-1 Weight Loss Injection Sales Share by Type (2021-2032) Figure 56. China GLP-1 Weight Loss Injection Revenue Share by Application (2021-2032) Figure 57. China GLP-1 Weight Loss Injection Sales Share by Application (2021-2032) Figure 58. Asia GLP-1 Weight Loss Injection Revenue Share by Type (2021-2032) Figure 59. Asia GLP-1 Weight Loss Injection Sales Share by Type (2021-2032) Figure 60. Asia GLP-1 Weight Loss Injection Revenue Share by Application (2021-2032) Figure 61. Asia GLP-1 Weight Loss Injection Sales Share by Application (2021-2032) Figure 62. Asia GLP-1 Weight Loss Injection Revenue Share by Country (2021-2032) Figure 63. Asia GLP-1 Weight Loss Injection Sales Share by Country (2021-2032) Figure 64. SAMEA GLP-1 Weight Loss Injection Revenue Share by Type (2021-2032) Figure 65. SAMEA GLP-1 Weight Loss Injection Sales Share by Type (2021-2032) Figure 66. SAMEA GLP-1 Weight Loss Injection Revenue Share by Application (2021-2032) Figure 67. SAMEA GLP-1 Weight Loss Injection Sales Share by Application (2021-2032) Figure 68. SAMEA GLP-1 Weight Loss Injection Revenue Share by Country (2021-2032) Figure 69. SAMEA GLP-1 Weight Loss Injection Sales Share by Country (2021-2032) Figure 70. GLP-1 Weight Loss Injection Value Chain Figure 71. Manufacturing Cost Structure Figure 72. GLP-1 Weight Loss Injection Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Tirzepatide
  • Semaglutide
  • Liraglutide
  • Benaglutide
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Novo Nordisk
  • Imeik
  • Borui Pharmaceuticals
  • Gan & Lee Pharmaceuticals
  • Hansoh Pharmaceuticals
  • Hengrui Medicine
  • Huadong Medicine
  • Eli Lilly
  • Shanghai Benemae Biopharmaceuticals Co., Ltd.
  • CSPC Pharmaceutical Group
  • Sihuan Pharmaceuticals
  • Wanbang Biopharma
  • Innovent Biologics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 GLP-1 Weight Loss Injection Market by Type
  3. 1.2.1 Global GLP-1 Weight Loss Injection Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Tirzepatide
  5. 1.2.3 Semaglutide
  6. 1.2.4 Liraglutide
  7. 1.2.5 Benaglutide
  8. 1.2.6 Others
  9. 1.3 GLP-1 Weight Loss Injection Market by Application
  10. 1.3.1 Global GLP-1 Weight Loss Injection Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Hospital
  12. 1.3.3 Clinic
  13. 1.3.4 Others
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 GLP-1 Weight Loss Injection Market Dynamics
  1. 2.1 GLP-1 Weight Loss Injection Industry Trends
  2. 2.2 GLP-1 Weight Loss Injection Industry Drivers
  3. 2.3 GLP-1 Weight Loss Injection Industry Opportunities and Challenges
  4. 2.4 GLP-1 Weight Loss Injection Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global GLP-1 Weight Loss Injection Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global GLP-1 Weight Loss Injection Revenue by Region
  3. 3.2.1 Global GLP-1 Weight Loss Injection Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global GLP-1 Weight Loss Injection Revenue by Region (2021-2026)
  5. 3.2.3 Global GLP-1 Weight Loss Injection Revenue by Region (2027-2032)
  6. 3.2.4 Global GLP-1 Weight Loss Injection Revenue Market Share by Region (2021-2032)
  7. 3.3 Global GLP-1 Weight Loss Injection Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global GLP-1 Weight Loss Injection Sales by Region
  9. 3.4.1 Global GLP-1 Weight Loss Injection Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global GLP-1 Weight Loss Injection Sales by Region (2021-2026)
  11. 3.4.3 Global GLP-1 Weight Loss Injection Sales by Region (2027-2032)
  12. 3.4.4 Global GLP-1 Weight Loss Injection Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global GLP-1 Weight Loss Injection Revenue by Manufacturers
  2. 4.1.1 Global GLP-1 Weight Loss Injection Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global GLP-1 Weight Loss Injection Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global GLP-1 Weight Loss Injection Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global GLP-1 Weight Loss Injection Sales by Manufacturers
  6. 4.2.1 Global GLP-1 Weight Loss Injection Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global GLP-1 Weight Loss Injection Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global GLP-1 Weight Loss Injection Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global GLP-1 Weight Loss Injection Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global GLP-1 Weight Loss Injection Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global GLP-1 Weight Loss Injection Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global GLP-1 Weight Loss Injection Manufacturers, Product Type & Application
  13. 4.7 Global GLP-1 Weight Loss Injection Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global GLP-1 Weight Loss Injection Market CR5 and HHI
  16. 4.8.2 2025 GLP-1 Weight Loss Injection Tier 1, Tier 2, and Tier 3
5 GLP-1 Weight Loss Injection Market by Type
  1. 5.1 Global GLP-1 Weight Loss Injection Revenue by Type
  2. 5.1.1 Global GLP-1 Weight Loss Injection Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global GLP-1 Weight Loss Injection Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global GLP-1 Weight Loss Injection Revenue Market Share by Type (2021-2032)
  5. 5.2 Global GLP-1 Weight Loss Injection Sales by Type
  6. 5.2.1 Global GLP-1 Weight Loss Injection Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global GLP-1 Weight Loss Injection Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global GLP-1 Weight Loss Injection Sales Market Share by Type (2021-2032)
  9. 5.3 Global GLP-1 Weight Loss Injection Price by Type
6 GLP-1 Weight Loss Injection Market by Application
  1. 6.1 Global GLP-1 Weight Loss Injection Revenue by Application
  2. 6.1.1 Global GLP-1 Weight Loss Injection Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global GLP-1 Weight Loss Injection Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global GLP-1 Weight Loss Injection Revenue Market Share by Application (2021-2032)
  5. 6.2 Global GLP-1 Weight Loss Injection Sales by Application
  6. 6.2.1 Global GLP-1 Weight Loss Injection Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global GLP-1 Weight Loss Injection Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global GLP-1 Weight Loss Injection Sales Market Share by Application (2021-2032)
  9. 6.3 Global GLP-1 Weight Loss Injection Price by Application
7 Company Profiles
  1. 7.1 Novo Nordisk
  2. 7.1.1 Novo Nordisk Company Information
  3. 7.1.2 Novo Nordisk Business Overview
  4. 7.1.3 Novo Nordisk GLP-1 Weight Loss Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Novo Nordisk GLP-1 Weight Loss Injection Product Portfolio
  6. 7.1.5 Novo Nordisk Recent Developments
  7. 7.2 Imeik
  8. 7.2.1 Imeik Company Information
  9. 7.2.2 Imeik Business Overview
  10. 7.2.3 Imeik GLP-1 Weight Loss Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Imeik GLP-1 Weight Loss Injection Product Portfolio
  12. 7.2.5 Imeik Recent Developments
  13. 7.3 Borui Pharmaceuticals
  14. 7.3.1 Borui Pharmaceuticals Company Information
  15. 7.3.2 Borui Pharmaceuticals Business Overview
  16. 7.3.3 Borui Pharmaceuticals GLP-1 Weight Loss Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Borui Pharmaceuticals GLP-1 Weight Loss Injection Product Portfolio
  18. 7.3.5 Borui Pharmaceuticals Recent Developments
  19. 7.4 Gan & Lee Pharmaceuticals
  20. 7.4.1 Gan & Lee Pharmaceuticals Company Information
  21. 7.4.2 Gan & Lee Pharmaceuticals Business Overview
  22. 7.4.3 Gan & Lee Pharmaceuticals GLP-1 Weight Loss Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Gan & Lee Pharmaceuticals GLP-1 Weight Loss Injection Product Portfolio
  24. 7.4.5 Gan & Lee Pharmaceuticals Recent Developments
  25. 7.5 Hansoh Pharmaceuticals
  26. 7.5.1 Hansoh Pharmaceuticals Company Information
  27. 7.5.2 Hansoh Pharmaceuticals Business Overview
  28. 7.5.3 Hansoh Pharmaceuticals GLP-1 Weight Loss Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Hansoh Pharmaceuticals GLP-1 Weight Loss Injection Product Portfolio
  30. 7.5.5 Hansoh Pharmaceuticals Recent Developments
  31. 7.6 Hengrui Medicine
  32. 7.6.1 Hengrui Medicine Company Information
  33. 7.6.2 Hengrui Medicine Business Overview
  34. 7.6.3 Hengrui Medicine GLP-1 Weight Loss Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Hengrui Medicine GLP-1 Weight Loss Injection Product Portfolio
  36. 7.6.5 Hengrui Medicine Recent Developments
  37. 7.7 Huadong Medicine
  38. 7.7.1 Huadong Medicine Company Information
  39. 7.7.2 Huadong Medicine Business Overview
  40. 7.7.3 Huadong Medicine GLP-1 Weight Loss Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Huadong Medicine GLP-1 Weight Loss Injection Product Portfolio
  42. 7.7.5 Huadong Medicine Recent Developments
  43. 7.8 Eli Lilly
  44. 7.8.1 Eli Lilly Company Information
  45. 7.8.2 Eli Lilly Business Overview
  46. 7.8.3 Eli Lilly GLP-1 Weight Loss Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Eli Lilly GLP-1 Weight Loss Injection Product Portfolio
  48. 7.8.5 Eli Lilly Recent Developments
  49. 7.9 Shanghai Benemae Biopharmaceuticals Co., Ltd.
  50. 7.9.1 Shanghai Benemae Biopharmaceuticals Co., Ltd. Company Information
  51. 7.9.2 Shanghai Benemae Biopharmaceuticals Co., Ltd. Business Overview
  52. 7.9.3 Shanghai Benemae Biopharmaceuticals Co., Ltd. GLP-1 Weight Loss Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Shanghai Benemae Biopharmaceuticals Co., Ltd. GLP-1 Weight Loss Injection Product Portfolio
  54. 7.9.5 Shanghai Benemae Biopharmaceuticals Co., Ltd. Recent Developments
  55. 7.10 CSPC Pharmaceutical Group
  56. 7.10.1 CSPC Pharmaceutical Group Company Information
  57. 7.10.2 CSPC Pharmaceutical Group Business Overview
  58. 7.10.3 CSPC Pharmaceutical Group GLP-1 Weight Loss Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 CSPC Pharmaceutical Group GLP-1 Weight Loss Injection Product Portfolio
  60. 7.10.5 CSPC Pharmaceutical Group Recent Developments
  61. 7.11 Sihuan Pharmaceuticals
  62. 7.11.1 Sihuan Pharmaceuticals Company Information
  63. 7.11.2 Sihuan Pharmaceuticals Business Overview
  64. 7.11.3 Sihuan Pharmaceuticals GLP-1 Weight Loss Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Sihuan Pharmaceuticals GLP-1 Weight Loss Injection Product Portfolio
  66. 7.11.5 Sihuan Pharmaceuticals Recent Developments
  67. 7.12 Wanbang Biopharma
  68. 7.12.1 Wanbang Biopharma Company Information
  69. 7.12.2 Wanbang Biopharma Business Overview
  70. 7.12.3 Wanbang Biopharma GLP-1 Weight Loss Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Wanbang Biopharma GLP-1 Weight Loss Injection Product Portfolio
  72. 7.12.5 Wanbang Biopharma Recent Developments
  73. 7.13 Innovent Biologics
  74. 7.13.1 Innovent Biologics Company Information
  75. 7.13.2 Innovent Biologics Business Overview
  76. 7.13.3 Innovent Biologics GLP-1 Weight Loss Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Innovent Biologics GLP-1 Weight Loss Injection Product Portfolio
  78. 7.13.5 Innovent Biologics Recent Developments
8 North America
  1. 8.1 North America GLP-1 Weight Loss Injection Market Size by Type
  2. 8.1.1 North America GLP-1 Weight Loss Injection Revenue by Type (2021-2032)
  3. 8.1.2 North America GLP-1 Weight Loss Injection Sales by Type (2021-2032)
  4. 8.1.3 North America GLP-1 Weight Loss Injection Price by Type (2021-2032)
  5. 8.2 North America GLP-1 Weight Loss Injection Market Size by Application
  6. 8.2.1 North America GLP-1 Weight Loss Injection Revenue by Application (2021-2032)
  7. 8.2.2 North America GLP-1 Weight Loss Injection Sales by Application (2021-2032)
  8. 8.2.3 North America GLP-1 Weight Loss Injection Price by Application (2021-2032)
  9. 8.3 North America GLP-1 Weight Loss Injection Market Size by Country
  10. 8.3.1 North America GLP-1 Weight Loss Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America GLP-1 Weight Loss Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America GLP-1 Weight Loss Injection Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe GLP-1 Weight Loss Injection Market Size by Type
  2. 9.1.1 Europe GLP-1 Weight Loss Injection Revenue by Type (2021-2032)
  3. 9.1.2 Europe GLP-1 Weight Loss Injection Sales by Type (2021-2032)
  4. 9.1.3 Europe GLP-1 Weight Loss Injection Price by Type (2021-2032)
  5. 9.2 Europe GLP-1 Weight Loss Injection Market Size by Application
  6. 9.2.1 Europe GLP-1 Weight Loss Injection Revenue by Application (2021-2032)
  7. 9.2.2 Europe GLP-1 Weight Loss Injection Sales by Application (2021-2032)
  8. 9.2.3 Europe GLP-1 Weight Loss Injection Price by Application (2021-2032)
  9. 9.3 Europe GLP-1 Weight Loss Injection Market Size by Country
  10. 9.3.1 Europe GLP-1 Weight Loss Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe GLP-1 Weight Loss Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe GLP-1 Weight Loss Injection Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China GLP-1 Weight Loss Injection Market Size by Type
  2. 10.1.1 China GLP-1 Weight Loss Injection Revenue by Type (2021-2032)
  3. 10.1.2 China GLP-1 Weight Loss Injection Sales by Type (2021-2032)
  4. 10.1.3 China GLP-1 Weight Loss Injection Price by Type (2021-2032)
  5. 10.2 China GLP-1 Weight Loss Injection Market Size by Application
  6. 10.2.1 China GLP-1 Weight Loss Injection Revenue by Application (2021-2032)
  7. 10.2.2 China GLP-1 Weight Loss Injection Sales by Application (2021-2032)
  8. 10.2.3 China GLP-1 Weight Loss Injection Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia GLP-1 Weight Loss Injection Market Size by Type
  2. 11.1.1 Asia GLP-1 Weight Loss Injection Revenue by Type (2021-2032)
  3. 11.1.2 Asia GLP-1 Weight Loss Injection Sales by Type (2021-2032)
  4. 11.1.3 Asia GLP-1 Weight Loss Injection Price by Type (2021-2032)
  5. 11.2 Asia GLP-1 Weight Loss Injection Market Size by Application
  6. 11.2.1 Asia GLP-1 Weight Loss Injection Revenue by Application (2021-2032)
  7. 11.2.2 Asia GLP-1 Weight Loss Injection Sales by Application (2021-2032)
  8. 11.2.3 Asia GLP-1 Weight Loss Injection Price by Application (2021-2032)
  9. 11.3 Asia GLP-1 Weight Loss Injection Market Size by Country
  10. 11.3.1 Asia GLP-1 Weight Loss Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia GLP-1 Weight Loss Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia GLP-1 Weight Loss Injection Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA GLP-1 Weight Loss Injection Market Size by Type
  2. 12.1.1 SAMEA GLP-1 Weight Loss Injection Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA GLP-1 Weight Loss Injection Sales by Type (2021-2032)
  4. 12.1.3 SAMEA GLP-1 Weight Loss Injection Price by Type (2021-2032)
  5. 12.2 SAMEA GLP-1 Weight Loss Injection Market Size by Application
  6. 12.2.1 SAMEA GLP-1 Weight Loss Injection Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA GLP-1 Weight Loss Injection Sales by Application (2021-2032)
  8. 12.2.3 SAMEA GLP-1 Weight Loss Injection Price by Application (2021-2032)
  9. 12.3 SAMEA GLP-1 Weight Loss Injection Market Size by Country
  10. 12.3.1 SAMEA GLP-1 Weight Loss Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA GLP-1 Weight Loss Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA GLP-1 Weight Loss Injection Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 GLP-1 Weight Loss Injection Value Chain Analysis
  2. 13.1.1 GLP-1 Weight Loss Injection Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 GLP-1 Weight Loss Injection Production Mode & Process
  6. 13.2 GLP-1 Weight Loss Injection Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 GLP-1 Weight Loss Injection Distributors
  9. 13.2.3 GLP-1 Weight Loss Injection Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst